Biontech and Genmab's collaboration goes deeper than previously said
The partnership between Genmab and Biontech extends beyond the three current clinical projects evident in their pipelines. The two firms are also collaborating on a number of preclinical candidates that have yet to reach the public’s eye. (Corrected)
by ulrich quistgaard, translated by daniel pedersen
(Correction: The article previously stated that the candidate Gen1056 was already in a clinical phase. This now reads that the candidate is headed to clinic).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Genmab loses royalties case against Janssen
For subscribers
